The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Open accessAbstract
Direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) provides a unique opportunity to derive patient-specific stem cells with potential applications in tissue replacement therapies and without the ethical concerns of human embryonic stem cells (hESCs). However, cellular senescence, which contributes to aging and restricted longevity, has been described as a barrier to the derivation of iPSCs. Here we demonstrate, using an optimized protocol, that cellular senescence is not a limit to reprogramming and that age-related cellular physiology is reversible. Thus, we show that our iPSCs generated from senescent and centenarian cells have reset telomere size, gene expression profiles, oxidative stress, and mitochondrial metabolism, and are indistinguishable from hESCs. Finally, we show that senescent and centenarian-derived pluripotent stem cells are able to redifferentiate into fully rejuvenated cells. These results provide new insights into iPSC technology and pave the way for regenerative medicine for aged patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, induction of pluripotency in iPSCs resets the age signatures of the donor cells to a fetal stage (7–9).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Telomere length decreases with age due to cell proliferation in the absence of telomerase enzymes and is restored upon complete iPSC reprogramming (Lapasset et al., 2011).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Lapasset et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The rejuvenation of aging hallmarks has been extensively described during cellular reprogramming to pluripotency in vitro (Lapasset et al., 2011;Liu et al., 2011;Mahmoudi and Brunet, 2012;Rando and Chang, 2012), but the dynamics of this process remain poorly understood.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Several groups, including ours, have observed an amelioration of age-associated cellular phenotypes during in vitro cellular reprogramming”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“iPSC reprogramming reverses many age-associated changes, including telomere attrition and oxidative stress (Lapasset et al., 2011).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Early reports using cells derived from old donors to generate iPS cells demonstrated beneficial effects on senescence phenotypes and telomere length [26][27][28] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“but protocols relied upon rejuvenation through re-differentiation after iPS cell formation 20,26,28 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Early experiments in human cells were somewhat encouraging as they provide evidence that some of the biomarkers of aging (that is telomere lengths) were responding to the epigenetic reprogramming”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
In the citing paper
“Of note, senescent cells from elderly people could be reverted to a pluripotent state only by the additional over-expression of NANOG and LIN2 in addition to Oct3/4, Sox2, c-Myc, and KLF4.196”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [196]
In the citing paper
“A growing body of evidence, including the present study and a prior report of reprogramming of senescent human fibroblasts into induced pluripotent stem cells (iPSCs; ref. 48), suggests that near-senescent or senescent cells can be induced back into a proliferative state.”
From p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes (2013) · cites this paper as [48]
In the citing paper
“Reprogramming cells from elderly humans (as old as 101 years of age) into pluripotent cells erases many of the hallmarks of aging and restores a youthful gene expression profile that is maintained during differentiation (Lapasset et al., 2011; Mertens et al., 2015).”
From The Aging Epigenome (2016) · cites this paper as Lapasset et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“A common feature is the activation of the p53/p21 and p16/ pRb pathways, alteration of cell morphology and metabolism, increase in senescence-associated b-galactosidase (SA-b-Gal) activity, and formation of senescence-associated heterochromatic foci (SAHF) (Narita et al. 2003).”
BackgroundLinking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 1×
“It has been reported by several groups that cellular senescence is a barrier to reprogramming due to upregulation of p53, p16, and p21, which are also induced by some of the iPSC reprogramming factors (Banito et al. 2009; Kawamura et al. 2009; Li et al. 2009; Marion et al. 2009a; Utikal et al. 2009).”
BackgroundThe Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Direct cell reprogramming is a stochastic process amenable to acceleration
Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 938
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J. S., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 853
Cited by
Sorted by citations
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Stem cells: past, present, and future
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M. K., & Rybak, Z. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1165-5 · Cited by 1,977
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“This method has been described to successfully generate iPS cells from centenarian adult fibroblasts as well as from fibroblasts serially passaged to replicative senescence (199).”
MethodSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“This evidence correlates with studies showing that fibroblasts or T cells derived from centenarians reset their telomeres, which results in rejuvenation and sustained proliferation (Lapasset et al., 2011).”
ResultIn Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
“…or patients with Hutchinson-Gilford progeria syndrome, (HGPS) a disorder characterized by premature aging, resets telomere size, gene expression profiles, and levels of oxidative stress, resulting in the generation of rejuvenated cells (Lapasset et al., 2011; Liu et al., 2011; Zhang et al., 2011).”
Aging of blood can be tracked by DNA methylation changes at just three CpG sites
Weidner, C. I., Lin, Q., Koch, C. M., Eisele, L., Beier, F., Ziegler, P., Bauerschlag, D. O., Jöckel, K.-H., Erbel, R., Mühleisen, T. W., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r24 · Cited by 837
“These findings fit nicely with other recent observations that iPSCs generated from senescent cells or centenarian donors reset telomere length, gene expression profiles, and other physiological features to those of young cells [35,36].”
BackgroundResultInfluentialCellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
“More recently, however, iPS cells were successfully generated from replicatively senescent HDFs at a rate comparable with their proliferative counterparts (Lapasset et al. 2011).”
BackgroundHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
“, 2010) and loss of senescence markers (Lapasset et al., 2011) in iPSCs derived from old donors, suggesting that rejuvenation takes place during reprogramming.”
Mertens, J., Paquola, A. C. M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J. R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.001 · Cited by 765
“However, preservation of human age as a major pathogenic risk factor would seem unlikely, given that cells must transit the embryolike iPSC state, which likely rejuvenates old somatic cells back into an embryonic state (Lapasset et al., 2011; Maherali et al., 2007; Meissner et al., 2008).”
Epigenetic regulation of aging: implications for interventions of aging and diseases
Kang, W., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 732
“In 2011, senescent cells from centenarians or Hutchinson–Gilford progeria syndrome (HGPS) patients can be fully reprogrammed to a pluripotent state with a rejuvenated epigenome, suggesting the potential of reprogramming in the reversal of aging.(27,28) In 2015, a combination of dasatinib and quercetin was identified t…”
BackgroundCellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
“Also, a specific six-factor gene cocktail reversed cellular senescence of senescent and centenarian fibroblasts and reprogrammed them into pluripotent stem cells (94).”
BackgroundBooth, L. N., & Brunet, A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.013 · Cited by 499
“Reprogramming cells from elderly humans (as old as 101 years of age) into pluripotent cells erases many of the hallmarks of aging and restores a youthful gene expression profile that is maintained during differentiation (Lapasset et al., 2011; Mertens et al., 2015).”
BackgroundMead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505
The ageing epigenome and its rejuvenation
Zhang, W., Qu, J., Liu, G.-H., & Belmonte, J. C. I. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0204-5 · Cited by 458
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Giorgi, C., Marchi, S., Simões, I. C. M., Ren, Z., Morciano, G., Perrone, M., Patalas‐Krawczyk, P., Borchard, S., Jędrak, P., Pierzynowska, K., et al. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 484
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
Mitochondrial Regulation in Pluripotent Stem Cells
Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G., & Belmonte, J. C. I. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.005 · Cited by 375
“Recent studies have demonstrated that there is a strong connection between mitochondrial function and pluripotency (Ahlqvist et al., 2012; Folmes et al., 2011; Lapasset et al., 2011; Prigione et al., 2010; Zhang et al., 2011; Zhou et al., 2012).”
BackgroundMesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
Fitzsimmons, R., Mazurek, M. S., Soos, A., & Simmons, C. A. (2018) · Stem Cells International · doi:10.1155/2018/8031718 · Cited by 369
“Also favorably, especially for cells harvested from aged patients, once harvested cells are differentiated into the desired cell type after having been in a transient pluripotent state results in longer telomeres compared to the starting donor cell along with a “rejuvenated” epigenetic landscape with reduced aging-ass…”
BackgroundEvaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Mertens, J., Marchetto, M. C., Bardy, C., & Gage, F. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.46 · Cited by 307
Epigenetic changes during aging and their reprogramming potential
Kane, A. E., & Sinclair, D. A. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1570075 · Cited by 283
“Human senescent and centenarian fibroblasts can also be transformed into iPSCs with transfection of the OSKM factors, which restores gene expression profiles to those of young cells (Lapasset et al. 2011; Yagi et al. 2012).”
BackgroundTargeting senescent cells in translational medicine
Paez‐Ribes, M., González‐Gualda, E., Doherty, G. J., & Muñoz‐Espín, D. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810234 · Cited by 293
“Interestingly, pools of cells enriched in senescent cells from centenarians were reprogrammed in vitro to pluripotent stem cells (Lapasset et al, 2011).”
BackgroundGeneration of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts
Victor, M. B., Richner, M., Hermanstyne, T. O., Ransdell, J. L., Sobieski, C., Deng, P.-Y., Klyachko, V. A., Nerbonne, J. M., & Yoo, A. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.016 · Cited by 295
“Moreover, reprogramming somatic cells to iPSCs has been shown to reintroduce the embryonic state and therefore hinders the prospect of modeling late-onset disorders, although new methods are being developed that may overcome this barrier (Lapasset et al., 2011; Miller et al., 2013).”
The Molecular Balancing Act of p16INK4a in Cancer and Aging
LaPak, K. M., & Burd, C. E. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0350 · Cited by 304
“Therefore, novel reprogramming approaches aimed at curbing the senescent phenotypemay improve iPS technology for the future (163).”
Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing
Mahmoudi, S., Mancini, E., Xu, L., Moore, A., Jahanbani, F., Hebestreit, K., Srinivasan, R., Li, X., Devarajan, K., Prélot, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1658-5 · Cited by 285
Mertens, J., Reid, D. A., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 263
“This iPSC rejuvenation has been demonstrated at the level of epigenetic methylated DNA (mDNA) and the transcriptome (33, 46, 79, 89, 91), as well as in telomeres (84, 124) and several functional phenotypes, including mitochondrial function, cellular senescence, DNA damage, and others (72, 100, 107, 125).”
BackgroundBrowder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00183-2 · Cited by 253
Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts
Huh, C. J., Zhang, B., Victor, M. B., Dahiya, S., Batista, L. F., Horvath, S., & Yoo, A. S. (2016) · eLife · doi:10.7554/elife.18648 · Cited by 213
“…at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Huh, Christine J.; Zhang, Bo; Victor, Matheus B.; Dahiya, Sonika; Batista, Luis FZ; Horvath, Steve; and Yoo, Andrew S., ,"Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts."”
BackgroundProgramming and Reprogramming Cellular Age in the Era of Induced Pluripotency
Studer, L., Vera, E., & Cornacchia, D. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.05.004 · Cited by 192
“Initial studies in iPSC-derived fibroblasts were focused on a limited set of hallmarks that included mitochondrial stress response and cellular senescence (Lapasset et al., 2011).”
BackgroundSenescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
Gill, D., Parry, A., Santos, F., Okkenhaug, H., Todd, C. D., Hernando-Herraez, I., Stubbs, T. M., Milagre, I., & Reik, W. (2022) · eLife · doi:10.7554/elife.71624 · Cited by 185
“Intriguingly, iPSC reprogramming reverses many age-associated changes including telomere attrition and oxidative stress (Lapasset et al., 2011).”
BackgroundInfluentialLyu, G., Guan, Y., Zhang, C., Zong, L., Sun, L., Huang, X., Huang, L., Zhang, L., Tian, X., Zhou, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04994-z · Cited by 178
Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
Kudlová, N., Sanctis, J. B. D., & Hajdúch, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084168 · Cited by 186
Aging and reprogramming: a two-way street
Mahmoudi, S., & Brunet, A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.10.004 · Cited by 171
4D Genome Rewiring during Oncogene-Induced and Replicative Senescence
Sati, S., Bonev, B., Szabo, Q., Jost, D., Bensadoun, P., Serra, F., Loubiere, V., Papadopoulos, G. L., Rivera-Mulia, J.-C., Fritsch, L., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.007 · Cited by 170
Self-citationHigh-efficiency RNA-based reprogramming of human primary fibroblasts
Kogut, I., McCarthy, S. M., Pavlova, M., Astling, D. P., Chen, X., Jakimenko, A., Jones, K. L., Getahun, A., Cambier, J. C., Pasmooij, A. M. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03190-3 · Cited by 171
Tang, Y., Liu, M.-L., Zang, T., & Zhang, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00359 · Cited by 170
“This may be due to a lack of the preservation of aging status, since cell reprogramming must transit through an embryo-like pluripotent state accompanied by a loss of particular age-associated features (Lapasset et al., 2011).”
Backgroundp53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164
“48), suggests that near-senescent or senescent cells can be induced back into a proliferative state.”
Human induced pluripotent stem cells for modelling neurodevelopmental disorders
Ardhanareeswaran, K., Mariani, J., Coppola, G., Abyzov, A. S., & Vaccarino, F. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.45 · Cited by 162
Turning back time with emerging rejuvenation strategies
Mahmoudi, S., Xu, L., & Brunet, A. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0206-0 · Cited by 171
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases
Ji, S., Xiong, M., Chen, H., Liu, Y., Zhou, L., Hong, Y., Wang, M., Wang, C., Fu, X., & Sun, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01343-5 · Cited by 172
“Senescent and centenarian cells are revived through pluripotent reprogramming, and the iPSCs produced from these cells have reset telomere length, gene expression profiles, oxidative stress, and mitochondrial metabolism.(267) In addition, the fact that these SCs-derived iPSCs can redifferentiate into fully rejuvenated…”
BackgroundLiu, M.-L., Zang, T., & Zhang, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.018 · Cited by 164
Venables, J. P., Lapasset, L., Gadéa, G., Fort, P., Klinck, R., Irimia, M., Vignal, E., Thibault, P., Prinos, P., Chabot, B., et al. (2013) · Nature Communications · doi:10.1038/ncomms3480 · Cited by 153
Self-citationMarolt, D., Traweger, A., Gimona, M., & Redl, H. R. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00352 · Cited by 157
Poetsch, M. S., Strano, A., & Guan, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac020 · Cited by 144
Tăcutu, R., Budovsky, A., Yanai, H., & Fraifeld, V. E. (2011) · Aging · doi:10.18632/aging.100413 · Cited by 146
“[79] demonstrated that senescent cells and the cells derived from centenarians could be reprogrammed and eventually rejuvenated.”
BackgroundHuman iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature
Spitzhorn, L., Megges, M., Wruck, W., Rahman, M. S., Otte, J., Degistirici, Ö., Meisel, R., Sorg, R. V., Oreffo, R. O. C., & Adjaye, J. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1209-x · Cited by 141
The Information Theory of Aging
Lu, Y. R., Tian, X., & Sinclair, D. A. (2023) · Nature Aging · doi:10.1038/s43587-023-00527-6 · Cited by 141
“Expression of the four Yamanaka factors plus two others, Nanog and LIN28, reprograms senescent and centenarian fibroblasts into iPSCs with the signature of young cells, characteristics that are retained even after they have been converted back to fibroblasts 53 .”
DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan
Bergsma, T., & Rogaeva, E. A. (2020) · Neuroscience Insights · doi:10.1177/2633105520942221 · Cited by 145
Direct neuronal reprogramming: learning from and for development
Masserdotti, G., Gascón, S., & Götz, M. (2016) · Development · doi:10.1242/dev.092163 · Cited by 130
“Especially for the latter, direct reprogramming has the advantage of maintaining the age of the starter cell (Mertens et al., 2015), in contrast to the re-setting that occurs when generating induced pluripotent stem cells (Lapasset et al., 2011).”
BackgroundPutting the brakes on the cell cycle: mechanisms of cellular growth arrest
Pack, L. R., Daigh, L. H., & Meyer, T. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.05.005 · Cited by 139
“Finally, genetically reprogramming senescent cells through an iPSC state has recently been demonstrated to ameliorate features of senescence and aging both in vitro and in vivo, suggesting that increased stemness may be a route out of the senescent cell state [79,80].”
BackgroundEpigenetic Regulation of Cellular Senescence
Crouch, J. D., Shvedova, M., Thanapaul, R. J. R. S., Botchkarev, V. A., & Roh, D. S. (2022) · Cells · doi:10.3390/cells11040672 · Cited by 139
“This model has also been utilized in replicatively senescent human donor fibroblasts and human cell line fibroblasts [116].”
MethodMulti‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Chondronasiou, D., Gill, D., Mosteiro, L., Urdinguio, R. G., Berenguer‐Llergo, A., Aguilera, M., Durand, S., Aprahamian, F., Nirmalathasan, N., Abad, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13578 · Cited by 133
Cellular reprogramming and epigenetic rejuvenation
Simpson, D. J., Olova, N. N., & Chandra, T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01158-7 · Cited by 127
“morphology, function and number are improved [17, 36, 38, 39].”
Pluripotent stem cells escape from senescence-associated DNA methylation changesPreprint
Koch, C., Reck, K., Shao, K., Lin, Q., Joussen, S., Ziegler, P., Walenda, G., Drescher, W., Opalka, B., May, T., et al. (2012) · Genome Research · doi:10.1101/gr.141945.112 · Cited by 125
“The same holds true for the differentiated progeny of iPSC and ESC, indicating that these cells are not immortalized per se (Lapasset et al. 2011).”
BackgroundInfluentialAlzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116
“Conversion to iPSCs erases the aging signatures, such as telomere shortening, epigenetic marks of chromatin, and mitochondrial metabolism (Lapasset et al. 2011, Mertens et al. 2015).”
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 125
“When the OSKM reprogramming factors (i.e., Oct4, Sox2, Klf4, and c-Myc) were extended by Nanog and Lin28, senescent cells were readily reprogrammable and presented with a full reversion of their age-related phenotypes (Lapasset et al., 2011).”
BackgroundKim, Y., Zheng, X., Ansari, Z., Bunnell, M. C., Herdy, J. R., Traxler, L., Lee, H., Paquola, A. C. M., Blithikioti, C., Ku, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.105 · Cited by 117
“Several groups have previously shown that iPSC reprogramming results in clonal cell lines with rejuvenated mitochondria (Lapasset et al., 2011; Prigione et al., 2011; Suhr et al., 2010) and that iPSC-derived neurons lack age-related phenotypes in general (Huh et al.”
BackgroundSenescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 119
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
“found that their induction efficiency could be increased using a six-factor reprogramming cocktail (SOX2, OCT4, KLF4, NANOG, LIN28, and c-MYC) instead of the usual OSKM, which also eliminates the marks of cellular aging [82,83].”
BackgroundDrouin‐Ouellet, J., Lau, S., Brattås, P. L., Rylander Ottosson, D., Pircs, K., Grassi, D. A., Collins, L. M., Vuono, R., Andersson Sjöland, A., Westergren‐Thorsson, G., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607471 · Cited by 110
“…2009; Lee et al , 2009; Lafaille et al , 2012), a number of studies show that reprogramming into pluripotency resets the age of the cells such that the resulting neurons are very young (Maherali et al , 2007; Meissner et al , 2008; Lapasset et al , 2011; Miller et al , 2013; Mertens et al , 2015).”
Oxidative stress, aging, antioxidant supplementation and their impact on human health: An overview
Martemucci, G., Portincasa, P., Ciaula, A. D., Mariano, M., Centonze, V., & D‘Alessandro, A. G. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111707 · Cited by 112
Telomerase Protects Werner Syndrome Lineage-Specific Stem Cells from Premature Aging
Cheung, H.-H., Liu, X., Canterel-Thouennon, L., Li, L., Edmonson, C., & Rennert, O. M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.02.006 · Cited by 102
“Reprogramming of normally aged fibroblasts or diseases of laminopathies and Hutchinson-Gilford Progeria syndrome have been reported (Lapasset et al., 2011; Liu et al., 2011; Zhang et al., 2011).”
ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks
Ho, R., Sances, S., Gowing, G., Mathis, M. W., O’Rourke, J. G., Sahabian, A., Wichterle, H., Baloh, R. H., Sareen, D., & Svendsen, C. N. (2016) · Nature Neuroscience · doi:10.1038/nn.4345 · Cited by 103
“This is presumably due to resetting the epigenetic state to that of an embryo during iPSC production, which can occur with samples even over 90-years old [25].”
BackgroundReversal of Hepatocyte Senescence After Continuous In Vivo Cell Proliferation
Wang, M., Chen, F., Li, J., Liu, C.-C., Zhang, H., Xia, Y., Yu, B., You, P., Xiang, D., Lu, L., et al. (2014) · Hepatology · doi:10.1002/hep.27094 · Cited by 109
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110
“Although they have been successfully generated from cells of a centenarian individual [343,344] and individuals with FAD [345] and SAD [346], they may reset the aging phenotype [347].”
BackgroundNF-κB activation impairs somatic cell reprogramming in ageing
Soria‐Valles, C., Osorio, F. G., Gutiérrez‐Fernández, A., Angeles, A. D. L., Bueno, C., Menéndez, P. R., Martín-Subero, J. I., Daley, G. Q., Freije, J. M. P., & López-Otı́n, C. (2015) · Nature Cell Biology · doi:10.1038/ncb3207 · Cited by 97
RetractedExosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells
Bi, Y., Qiao, X., Cai, Z., Zhao, H., Ye, R., Liu, Q., Gao, L., Liu, Y., Liang, B., Liu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.11.013 · Cited by 101
Aging as an Epigenetic Phenomenon
Ashapkin, V. V., Kutueva, L. I., & Vanyushin, B. F. (2017) · Current Genomics · doi:10.2174/1389202918666170412112130 · Cited by 94
“Neither is it related to the cell senescence, since its correlation to the chronological age is observed in immortal cell lines, such as ESCs.”
BackgroundInfluentialChemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
Senescence-Associated Metabolomic Phenotype in Primary and iPSC-Derived Mesenchymal Stromal Cells
Fernández‐Rebollo, E., Franzen, J., Goetzke, R., Hollmann, J., Ostrowska, A., Oliverio, M., Sieben, T., Rath, B., Kornfeld, J., & Wagner, W. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.12.012 · Cited by 94
“In contrast to primary cells, such as MSCs, induced pluripotent stem cells (iPSCs) do not reveal any signs of replicative senescence (Koch et al., 2013; Lapasset et al., 2011).”
Bajpai, V., Mistriotis, P., Loh, Y., Daley, G., & Andreadis, S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs253 · Cited by 89
The aging signature: a hallmark of induced pluripotent stem cells?
Rohani, L., Johnson, A. A., Arnold, A., & Stolzing, A. (2013) · Aging Cell · doi:10.1111/acel.12182 · Cited by 88
“Mitochondrial morphology and distribution were also both comparable to ESCs (Lapasset et al., 2011).”
BackgroundResultInfluentialLu, J. Y., Simon, M. A., Zhao, Y., Ablaeva, J., Corson, N., Choi, Y., Yamada, K. Y. H., Schork, N. J., Hood, W. R., Hill, G. E., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.011 · Cited by 82
Son, M. J., Kwon, Y., Son, T., & Cho, Y. S. (2016) · Stem Cells · doi:10.1002/stem.2460 · Cited by 85
Chen, W., Tsai, P., Hung, Y., Chiou, S., & Mou, C. (2013) · ACS Nano · doi:10.1021/nn401418n · Cited by 85
Roux, A. E., Zhang, C., Paw, J., Zavala-Solorio, J., Malahias, E., Vijay, T., Kolumam, G., Kenyon, C., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 78
Yagi, T., Kosakai, A., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Nabetani, A., Ishikawa, F., Arai, Y., Hirose, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041572 · Cited by 84
Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo
Doeser, M. C., Schöler, H. R., & Wu, G. (2018) · Stem Cells · doi:10.1002/stem.2842 · Cited by 83
Anti-Aging Strategies Based on Cellular Reprogramming
Ocampo, A., Reddy, P., & Belmonte, J. C. I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.005 · Cited by 80
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms6971 · Cited by 80
Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77
“Similarly, LOAD spheroids from six independent individuals exhibited significantly (p 0.05) higher amounts of extracellular A β deposits at PID28 compared to age-matched HC spheroids (Fig.”
InfluentialAssou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 81
Yang, N., & Sen, P. (2018) · Aging · doi:10.18632/aging.101617 · Cited by 77
Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 66
“…et al., 2009), we developed an optimized iPSC- derived strategy to rejuvenate senescent cells and cells from centenarians individuals through the pluripotent state, using two additional factors NANOG and LIN28 (OSKMNL), demonstrating that cellular aging was reversible (Lapasset et al., 2011).”
MethodSelf-citationBrun, C., Jean‐Louis, F., Oddos, T., Bagot, M., Bensussan, A., & Michel, L. (2015) · Experimental Dermatology · doi:10.1111/exd.12874 · Cited by 75
Trokovic, R., Weltner, J., Noisa, P., Raivio, T., & Otonkoski, T. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.06.001 · Cited by 74
“Contrary to what has been observed in mice, donor age was suggested not to impair the reprogramming efficiency of human cells (Somers et al., 2010) and iPSC have been successfully derived even from the fibroblasts of centenarians (Lapasset et al., 2011).”
Cell Therapy Strategies to Combat Immunosenescence
Stahl, E. C., & Brown, B. N. (2015) · Organogenesis · doi:10.1080/15476278.2015.1120046 · Cited by 73
“In addition, the iPSCs were able to redifferentiate into fully rejuvenated cells.(62) Therefore, iPS technology may be the key to the fountain of youth, where any senescent cell could in theory be reborn.”
BackgroundCellular Plasticity: A Route to Senescence Exit and Tumorigenesis
Blander, H. D., Morel, A., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 82
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Francescangeli, F., Angelis, M. L. D., Rossi, R., Cuccu, A., Giuliani, A., Maria, R. D., & Zeuner, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10092-4 · Cited by 80
“Moreover, under certain circumstances, senescent cells can re-enter the cell cycle or be reprogrammed into iPSCs [112, 113].”
BackgroundAge Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
Strässler, E. T., Aalto‐Setälä, K., Kiamehr, M., Landmesser, U., & Kränkel, N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00004 · Cited by 71
“For instance, nuclear transfer leads to longer telomeres in derived stem cells (54) and seems to erase epigenetic memory better than cellular reprogramming, for NT-SCs are more similar in their DNA methylation patterns to ESCs than iPSCs (38).”
BackgroundInfluentialiPSC technology to study human aging and aging-related disorders
Liu, G., Ding, Z., & Belmonte, J. C. I. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.08.014 · Cited by 70
“Reprogramming toward pluripotency enables resetting of the cellular clock and removal of most, if not all, of the agingassociated cellular hallmarks [72 ,73,74].”
BackgroundProtein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., & Σκρέτας, Γ. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1383453 · Cited by 71
Induced pluripotent stem cells, a giant leap for mankind therapeutic applications
Bragança, J., Lopes, J. A., Mendes-Silva, L., & Santos, J. M. A. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i7.421 · Cited by 74
Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs
Cates, K., McCoy, M. J., Kwon, J.-S., Liu, Y., Abernathy, D. G., Zhang, B., Liu, S., Gontarz, P., Kim, W. K., Chen, S., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.08.015 · Cited by 67
Linking Telomere Regulation to Stem Cell Pluripotency
Liu, L. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.10.007 · Cited by 66
Cellular Reprogramming of Human Peripheral Blood Cells
Zhang, X. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.001 · Cited by 66
“The generation of iPSCs followed by directed differentiation will not only provide large quantities of patient-specific somatic (stem) cells for individualized therapy, but also raises hopes of rejuvenating cells from elderly patients [96,97].”
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Cipriano, A., Moqri, M., Maybury-Lewis, S. Y., Rogers-Hammond, R., de Jong, T. A., Parker, A., Rasouli, S., Schöler, H. R., Sinclair, D. A., & Sebastiano, V. (2023) · Nature Aging · doi:10.1038/s43587-023-00539-2 · Cited by 66
“Early experiments in human cells were somewhat encouraging as they provide evidence that some of the biomarkers of aging (that is telomere lengths) were responding to the epigenetic reprogramming, but protocols relied upon rejuvenation through re-differentiation after iPS cell formation 20,26,28 .”
Capano, L. S., Sato, C., Ficulle, E., Yu, A., Horie, K., Kwon, J.-S., Burbach, K. F., Barthélemy, N. R., Fox, S. G., Karch, C. M., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.018 · Cited by 65
Ageing in the brain: mechanisms and rejuvenating strategies
Gaspar-Silva, F., Trigo, D., & Magalhães, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04832-6 · Cited by 88
Metadata
- Authors
- Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., Lehmann, S., & Lemaitre, J.-M.
- Affiliations
- Institut de Génomique Fonctionnelle (FR)
- Hôpital Arnaud de Villeneuve (FR)
- Hôpital Saint Eloi (FR)
- Institut de Génétique Humaine (FR)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-11-01
- Volume
- 25
- Issue
- 21
- Pages
- 2248-2253
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3219229
- OpenAlex
- W2114840727
- Cited by
- 570
- References
- 31
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 46 · 2023: 49 · 2022: 53 · 2021: 49 · 2020: 38 · 2019: 40 · 2018: 49 · 2017: 33 · 2016: 33 · 2015: 30 · 2014: 29 · 2013: 25 · 2012: 23
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-07-BLAN-0076)
- Institut National de la Santé et de la Recherche Médicale
- Institut National Du Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- cellular senescence, induced pluripotent stem cells, direct reprogramming, aging, telomere length, oxidative stress, mitochondrial metabolism, gene expression profiles, redifferentiation, rejuvenation, regenerative medicine
- MeSH terms
- Aged, Aged, 80 and over, Animals, Cell Differentiation, Cell Line, Cells, Cultured, Humans, Mitochondria, Rejuvenation, Transcription Factors, Mice, SCID, Telomere, Mice, Inbred NOD, Cellular Senescence, Mice, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
